课题基金 / 基金详情

Targeting hyperapoB vs normoapoB to reduce the risk of type 2 diabetes in obese subjects; mechanism of action

Targeting hyperapoB vs normoapoB to reduce the risk of type 2 diabetes in obese subjects; mechanism of action
相对于normoapoB，靶向hyperapoB可降低肥胖受试者患2型糖尿病的风险；
批准号：
172911
负责人：
Faraj May
金额：
$29.5万
依托单位：
Universit de Montral
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-09-01 至 2011-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=172911&lang=en
关键词：
24 Weeks Hypocaloric Diet Intervention Blood & Adipose Tissue) Fatty Acid Trapping (In Vivo & Ex Vivo In Adipose Tissue) Inflammation (In Vivo & Ex Vivo Insulin Sensitivity (In Vivo & Ex Vivo In Adipose Tissue) Lipids & Apob-Lipoproteins (Size Numbe

项目摘要

项目成果

Faraj May的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background: Type 2 diabetes results in the yearly death of ~ 40,000 Canadians. Some obese subjects have higher risk to develop diabetes and my research will examine why. The risk for type 2 diabetes in obese subjects increases when the body is resistance
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
White adipose tissue LDL receptors and omega-3 as modulators of the risk for type 2 diabetes
The inflammasome and dysfunctional adipose tissue: why should apoB-lipoproteins be targeted in humans
ApoB-lipoproteins, adipose tissue NLRP3 inflammasome and insulin resistance